Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded at Zacks Research

Reckitt Benckiser Group (OTCMKTS:RBGLYGet Free Report) was upgraded by analysts at Zacks Research to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

Other equities research analysts have also issued research reports about the stock. Barclays upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 1st. Royal Bank Of Canada cut Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research report on Wednesday, January 14th. Citigroup initiated coverage on Reckitt Benckiser Group in a research report on Wednesday, January 14th. They set a “buy” rating for the company. Morgan Stanley downgraded Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 15th. Finally, Jefferies Financial Group reiterated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Wednesday, January 7th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

View Our Latest Research Report on RBGLY

Reckitt Benckiser Group Stock Performance

RBGLY stock opened at $16.25 on Tuesday. Reckitt Benckiser Group has a 1-year low of $12.49 and a 1-year high of $17.80. The firm has a fifty day moving average price of $16.81 and a two-hundred day moving average price of $15.97. The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.